We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+26.23%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$2.44B
AUM Growth
+$792M
Cap. Flow
+$442M
Cap. Flow %
18.15%
Top 10 Hldgs %
14.39%
Holding
5,222
New
2,059
Increased
1,821
Reduced
839
Closed
374

Top Buys

Rank Stock Value
1
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$55.3M
2
AAPL icon
Apple
AAPL
+$33.2M
3
AMZN icon
Amazon
AMZN
+$29.2M
4
MSFT icon
Microsoft
MSFT
+$26.4M
5
SOXL icon
Direxion Daily Semiconductor Bull 3X ETF
SOXL
+$22.1M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$342M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$93.3M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$86M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$51.5M
5
XLU icon
State Street Utilities Select Sector SPDR ETF
XLU
+$29.6M

Sector Composition

Rank Sector Weight
1 Technology 12.14%
2 Healthcare 9.57%
3 Financials 8.79%
4 Industrials 7.76%
5 Consumer Discretionary 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RSPD icon
3876
Invesco S&P 500 Equal Weight Consumer Discretionary ETF
RSPD
$336M
$14K ﹤0.01%
465
-16,161
-97% -$442K
RSSS icon
3877
Research Solutions
RSSS
$72.2M
$14K ﹤0.01%
+5,776
New +$16.6K
GRDX
3878
GridAI Technologies Corp
GRDX
$21.1M
– –
0
– –
BPTH
3879
DELISTED
Bio-Path Holdings Inc
BPTH
$14K ﹤0.01%
+135
New +$14K
ORTX
3880
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$14K ﹤0.01%
+229
New +$21K
AGFS
3881
DELISTED
AgroFresh Solutions Inc
AGFS
$14K ﹤0.01%
+4,539
New +$11.2K
CNNB
3882
DELISTED
CINCINNATI BANCORP
CNNB
$14K ﹤0.01%
+1,556
New +$13.5K
CFMS
3883
DELISTED
Conformis, Inc. Common Stock
CFMS
$14K ﹤0.01%
660
+567
+610% +$11.9K
CYBE
3884
DELISTED
Cyberoptics Corp
CYBE
$14K ﹤0.01%
+450
New +$12.6K
PHAS
3885
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$14K ﹤0.01%
3,060
+2,236
+271% +$9.9K
TRIL
3886
DELISTED
Trillium Therapeutics Inc.
TRIL
$14K ﹤0.01%
+1,713
New +$10.6K
NAVB
3887
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$14K ﹤0.01%
+3,558
New +$6.8K
UN
3888
DELISTED
Unilever NV New York Registry Shares
UN
$14K ﹤0.01%
269
+192
+249% +$9.76K
AL
3889
DELISTED
Air Lease Corp
AL
$13K ﹤0.01%
+432
New +$11.5K
AMS icon
3890
American Shared Hospital Services
AMS
$10.1M
$13K ﹤0.01%
6,237
+6,197
+15,493% +$11.1K
CGBD icon
3891
Carlyle Secured Lending
CGBD
$766M
$13K ﹤0.01%
1,469
-16,273
-92% -$127K
COCP icon
3892
Cocrystal Pharma
COCP
$14.9M
$13K ﹤0.01%
+721
New +$8.84K
DARE icon
3893
Dare Bioscience
DARE
$20.4M
$13K ﹤0.01%
+1,118
New +$13.7K
DBC icon
3894
Invesco DB Commodity Index Tracking Fund
DBC
$1.72B
$13K ﹤0.01%
+1,049
New +$12.1K
DOYU
3895
DouYu International Holdings
DOYU
$134M
$13K ﹤0.01%
+110
New +$9.19K
ECC
3896
Eagle Point Credit Company
ECC
$512M
$13K ﹤0.01%
1,768
+841
+91% +$5.49K
EDC icon
3897
Direxion Daily MSCI Emerging Markets Bull 3X ETF
EDC
$157M
$13K ﹤0.01%
283
-148
-34% -$5.55K
GLAD icon
3898
Gladstone Capital
GLAD
$440M
$13K ﹤0.01%
899
-5,421
-86% -$72K
HEFA icon
3899
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.75B
$13K ﹤0.01%
+465
New +$12.2K
JAKK icon
3900
Jakks Pacific
JAKK
$291M
$13K ﹤0.01%
+1,632
New +$10.7K
154 155
156
157 158

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2020 Portfolio in Review

As of Q2 2020, Tower Research Capital (TRC) held 5,222 positions worth $2.44B, up 48% from $1.64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) deployed $442M of net new capital in Q2 2020, opening 2,059 new positions and adding to 1,821 existing holdings. Its largest new stake was Apple: 428,252 shares worth $39.1M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $342M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2020 buy was Apple: 428,252 shares worth $39.1M.
  • Tower Research Capital (TRC) added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, an estimated $55.3M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $342M.
  • Tower Research Capital (TRC) fully exited First Trust Technology AlphaDEX Fund in Q2 2020, selling an estimated $2.52M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $2.44B portfolio in Q2 2020.
  • Tower Research Capital (TRC) opened 2,059 new positions and closed 374 in Q2 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $2.44B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2020, filed 13 Aug 2020.